Case Study: Regional Wholesale Distributor Achieves NABP DDA Accreditation After DSCSA Gap Identified
Situation Overview
A regional wholesale drug distributor serving independent pharmacy customers across four Midwestern states contacted IHS after one of its major pharmacy chain customers issued a supplier qualification notice requiring all distributors in its network to hold NABP Drug Distributor Accreditation (DDA) — formerly VAWD — within 12 months or face removal from the approved supplier list. The distributor had operated for over a decade with all required state wholesale distributor licenses but had never pursued DDA. Its leadership team had assumed that state licensure was sufficient and was unfamiliar with the DDA process.
Challenges
- DSCSA compliance gaps: The facility had not fully transitioned to the electronic interoperable tracing requirements that took effect in late 2024. Transaction data was being exchanged via a mix of paper records and a legacy EDI system that did not meet NABP's current DSCSA verification standards.
- Documentation deficiencies: Existing SOPs had not been updated in over four years and did not reflect current operations, personnel roles, or regulatory requirements. Several key procedures — including suspect product quarantine and recall notification — were absent entirely.
- Supplier qualification program: The facility lacked a formal written supplier qualification program. Purchasing decisions were made based on longstanding relationships without documented verification of supplier licensure and authorization status.
- Compressed timeline: The pharmacy chain customer's 12-month deadline left limited time for the full DDA process, including documentation development, NABP inspection scheduling, and any corrective actions resulting from the inspection.
IHS Approach
IHS conducted an initial engagement kick-off with the distributor's operations director and compliance officer. Thomas G. Goddard, JD, PhD — IHS's principal consultant and former Chief Operating Officer and General Counsel of URAC — led the engagement directly.
Phase 1: Gap Assessment (Weeks 1–3)
IHS performed a structured gap assessment against the current DDA criteria, reviewing all existing policies, procedures, licensure documentation, facility design, personnel records, and DSCSA compliance infrastructure. The assessment produced a prioritized remediation roadmap identifying 23 discrete gaps across six DDA criteria areas, with each gap assigned a severity rating, responsible owner, and target completion date calibrated to the inspection timeline.
Phase 2: Documentation Overhaul (Weeks 4–12)
IHS developed or substantially revised 31 SOPs, including product receipt and verification, storage and environmental control monitoring, order fulfillment and shipping, supplier qualification, suspect and illegitimate product handling, recall execution, returns processing, and employee training. All SOPs were written to reflect actual facility operations confirmed through walkthrough interviews with operations staff. A formal supplier qualification program — including a checklist for verifying supplier licensure, DEA registration, and DSCSA authorization — was established and populated with current documentation for all active suppliers.
Phase 3: DSCSA Remediation (Weeks 8–16)
The most technically complex gap involved upgrading the facility's DSCSA compliance infrastructure. IHS worked with the distributor's IT team and a DSCSA technology vendor to replace the legacy EDI system with a compliant electronic product tracing platform capable of generating, receiving, and verifying serialized transaction data. IHS reviewed the vendor's data formats and trading partner agreements against DSCSA requirements to confirm compliance before go-live.
Phase 4: Mock Inspection (Week 18)
IHS conducted a full-day mock inspection at the facility, replicating the NABP inspection process including documentation review, facility walkthrough, and staff interviews. The mock inspection identified three remaining minor documentation gaps — primarily in training record completeness and environmental monitoring log formatting — that were resolved in the two weeks following.
Phase 5: NABP Inspection and Post-Inspection
The NABP on-site inspection occurred in month 6 of the engagement. The inspection produced two findings: a minor formatting issue with transaction documentation and one SOP that required clarification of escalation procedures for suspect product. IHS prepared the corrective action plan within 10 business days of receiving the inspection report. NABP accepted the CAP without requiring re-inspection, and the facility received DDA accreditation in month 8 of the engagement — well within the pharmacy chain's 12-month deadline.
Outcomes
- DDA accreditation granted in month 8, four months ahead of the trading partner deadline
- Full DSCSA electronic interoperable tracing capability operational before the NABP inspection
- 31 SOPs developed or revised, all reflecting current operations and current regulatory requirements
- Formal supplier qualification program established with documentation for all active suppliers
- Only two minor inspection findings, both resolved without re-inspection
- Trading partner relationship preserved; distributor retained on approved supplier list
- Two additional pharmacy chain customers subsequently required DDA from the same distributor — accreditation was already in hand
Key Lessons
State licensure alone is no longer sufficient for market access. The distributor had operated legally for over a decade with state licenses only. A single trading partner requirement changed its competitive position overnight. DDA is increasingly a commercial prerequisite, not just a regulatory one.
DSCSA compliance cannot be deferred. The legacy EDI system that had served this distributor for years was not compliant with 2024–2025 DSCSA requirements. Addressing this gap required the most time in the engagement. Distributors who have not audited their DSCSA infrastructure against current requirements should do so before initiating a DDA application.
Documentation must reflect actual operations. Generic or outdated SOPs are identified immediately during NABP inspections. The investment in accurate, operations-specific documentation is the single most impactful action a distributor can take before scheduling an inspection.
Facing a Similar Situation?
Whether you are responding to a trading partner requirement, a state licensure mandate, or proactively pursuing DDA, IHS provides the structured, principal-led consulting engagement that gets you to accreditation efficiently. Schedule a Free Discovery Session to discuss your timeline and readiness.